http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0153299-A9
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-24 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4995 |
| filingDate | 2001-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bedd8c93ac5e0fd150d5ce7f82b400fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2120a61146ea137abc12f10da3847939 |
| publicationDate | 2002-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-0153299-A9 |
| titleOfInvention | Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof |
| abstract | Compounds of the saframycin-ecteinascidin series with cytotoxic properties having the general formula (1), their uses and synthesis, are disclosed. In said formula, R1 and R4 is H, a C1 to C4 alkyl group, or an acyl group; R2 is an ether, ester, amide, or a phthalimide group; R3 is =O, OH, an ether group, an acyl group such as OC(O)Me, OC(O)Bn and OC(O)Et, or a sulfide group; R5 is H, halogen, OH, an ether group, an acyl group, or an amide group; R6 is =O, OH, OCH3, CN, or an acyfoxy group; wherein R7 is =0, OH, halogen, an ether group, or an acyl group; wherein R8 and R9 are independently H, CH3, OCH3 OC2H5, CF3, halogen such as Br and F, or R8 and R9 are joined together as a methylenedioxy group, or other five or six membered ring; R10 and R11 are independently CH3, OCH3, OC2H5, SCH3, or SC2H5; R12 is H, a C1 to C4 alkyl group, or an acyl group; and the chiral center marked * has the R or the S configuration. |
| priorityDate | 2000-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 142.